Getting diagnosed with dementia is not a single test but a multi-step process that typically involves cognitive screening, blood work, brain imaging, and an assessment of how well you manage daily life. No one scan or quiz can confirm dementia on its own. Instead, doctors piece together evidence from several angles to determine whether cognitive decline is present, how severe it is, and what’s causing it.
What Happens at the First Visit
The process usually starts with a primary care doctor or a specialist such as a neurologist or geriatric psychiatrist. They’ll take a detailed history, not just from you but often from a family member or close friend who can describe changes they’ve noticed. Doctors want to know when problems started, how quickly they’ve progressed, and which areas of thinking seem affected. They’ll also review your medications, since some drugs can cause confusion or memory problems that mimic dementia.
A physical and neurological exam comes next. The doctor checks reflexes, balance, coordination, eye movements, and sensation. These basic checks can reveal signs of stroke, Parkinson’s disease, or other neurological conditions that affect cognition differently than Alzheimer’s does.
Cognitive Screening Tests
One of the earliest tools your doctor will use is a brief cognitive screening test, usually done right in the office. The two most common are the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA). Both take about 10 to 15 minutes and involve tasks like remembering a short list of words, drawing a clock face, counting backward, and naming the current date and location.
The MMSE is scored out of 30. A score of 25 or higher is considered normal, while anything below 24 raises concern for cognitive impairment. The MoCA uses a similar 30-point scale and is often preferred because it’s better at catching early or mild problems, particularly with attention and executive function. These screenings aren’t diagnostic by themselves. They flag whether more detailed testing is needed.
Neuropsychological Testing
If screening suggests a problem, you may be referred for a full neuropsychological evaluation. This is a much longer session, often two to four hours, conducted by a neuropsychologist. It maps out your cognitive strengths and weaknesses across several specific areas: learning and memory, executive functions like planning and problem-solving, language, attention, and visuospatial skills (your ability to judge distances, copy shapes, or understand how objects relate to each other in space).
The results create a detailed profile. Someone with early Alzheimer’s disease, for example, tends to show steep declines in short-term memory while language skills remain relatively intact. Someone with frontotemporal dementia might show the reverse pattern, with personality changes and language trouble but preserved memory early on. This profile helps doctors distinguish between types of dementia and separate true decline from normal aging or depression-related cognitive slowing.
Blood Tests to Rule Out Reversible Causes
Before labeling cognitive decline as dementia, doctors need to eliminate conditions that can look like dementia but are treatable. Blood work screens for vitamin B12 deficiency, thyroid dysfunction, blood sugar abnormalities, kidney or liver problems, and certain infections known to affect the brain, including HIV and syphilis. A complete blood count, urinalysis, and sometimes a toxicology screen for drugs or alcohol are also part of the workup.
This step matters more than many people realize. Low B12 levels, an underactive thyroid, or medication side effects can all cause memory loss, confusion, and difficulty concentrating. Catching these means the cognitive symptoms may be partially or fully reversible with treatment.
Brain Imaging
Most people being evaluated for dementia will get at least one brain scan, typically an MRI or CT scan. These structural images let doctors look for patterns of brain shrinkage, signs of past strokes, tumors, fluid buildup, or areas of damage in specific regions.
Doctors look for several specific patterns. Shrinkage in the medial temporal lobe (the area deep in the brain involved in forming new memories) is a hallmark of Alzheimer’s disease. They also assess overall cortical atrophy, white matter lesions that suggest blood vessel disease, and shrinkage toward the back of the brain. MRI provides a clearer picture than CT, especially for detecting small blood vessel damage and for imaging structures near the base of the skull, but CT is sometimes used when MRI isn’t an option.
These scans don’t diagnose dementia directly. A person can have some brain shrinkage and still function normally. But combined with cognitive test results and clinical history, imaging patterns help confirm the diagnosis and point toward the underlying cause.
When Advanced Scans Are Used
PET scans that detect amyloid plaques or tau protein tangles in the brain are not part of a routine dementia workup. Updated guidelines from the Alzheimer’s Association and the Society for Nuclear Medicine and Molecular Imaging specify that these scans are appropriate mainly when Alzheimer’s disease is suspected as the likely cause of cognitive decline but the diagnosis remains uncertain after a full evaluation. They’re also used to determine eligibility for newer amyloid-targeting therapies.
Amyloid and tau PET scans are considered rarely appropriate for people who are cognitively normal, even if they have risk factors like a family history of Alzheimer’s or carry a known genetic risk variant. The scans are not meant to replace the standard clinical workup. They add a layer of certainty in ambiguous cases.
Blood Tests for Alzheimer’s Biomarkers
A significant recent development is the FDA’s clearance of the first blood test to aid in diagnosing Alzheimer’s disease. The test measures a ratio of two proteins in the blood that reflect amyloid plaque buildup in the brain. In a clinical study of 499 cognitively impaired adults, 91.7% of people who tested positive on the blood test were confirmed to have amyloid plaques by PET scan or spinal fluid analysis. Among those who tested negative, 97.3% were confirmed negative by those same reference methods.
The test is approved for adults 55 and older who are already showing signs of cognitive impairment. It’s not a standalone diagnostic tool, but it could reduce the need for expensive PET scans or invasive spinal taps in some cases. Less than 20% of participants in the study received an indeterminate result, meaning the test couldn’t give a clear answer.
Assessing Daily Functioning
A dementia diagnosis requires more than just poor test scores. Doctors also need to establish that cognitive decline is interfering with your ability to function independently. This is a core part of the diagnostic criteria: the distinction between mild cognitive impairment (where you notice problems but still manage daily life) and dementia (where those problems start limiting what you can do on your own).
Clinicians assess two tiers of daily activities. Instrumental activities are the more complex tasks of independent living: managing finances, taking medications correctly, preparing meals, using transportation, doing housework, and handling a phone. Basic activities are more fundamental: bathing, dressing, eating, and using the bathroom. Someone with mild dementia typically struggles with the instrumental tasks first. Moderate dementia brings difficulty with basic self-care, and severe dementia means full dependence on others.
Doctors often gather this information through structured questionnaires filled out by a family member or caregiver, since the person with dementia may not recognize how much their abilities have changed.
How Long the Process Takes
From the first appointment to a formal diagnosis, the process can take anywhere from a few weeks to several months. The initial visit, blood work, and brain imaging can often be completed within a few weeks. Neuropsychological testing may involve a longer wait depending on availability. If advanced imaging or specialist consultations are needed, the timeline extends further.
Some people receive a diagnosis of mild cognitive impairment first, with follow-up testing scheduled six to twelve months later to see whether decline has progressed. Dementia isn’t always obvious in its earliest stages, and doctors sometimes need that window of time to distinguish a true progressive condition from a temporary or stable one.
What the Diagnosis Looks Like
A dementia diagnosis isn’t just a yes or no. It typically includes the severity level (mild, moderate, or severe), the suspected underlying cause (Alzheimer’s disease, vascular dementia, Lewy body dementia, frontotemporal dementia, or a mixed picture), and an assessment of which cognitive domains are most affected. This specificity matters because different types of dementia progress differently and respond to different management strategies.
Getting to this level of detail is exactly why the process involves so many steps. Each layer of testing eliminates possibilities, narrows the cause, and gives you and your family a clearer picture of what to expect and plan for.